Scleroderma overview: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 38: | Line 38: | ||
===Echocardiography or Ultrasound=== | ===Echocardiography or Ultrasound=== | ||
===Other Imaging Findings | ===Other Imaging Findings=== | ||
==Treatment== | ==Treatment== | ||
Revision as of 16:51, 13 June 2016
|
Scleroderma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Scleroderma overview On the Web |
|
American Roentgen Ray Society Images of Scleroderma overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Scleroderma is a rare, chronic disease characterized by excessive deposits of collagen in the skin or other organs. The localized type of the disease, while disabling, tends not to be fatal. Diffuse scleroderma or systemic sclerosis, the generalized type of the disease, can be fatal as a result of heart, kidney, lung or intestinal damage.[1]
Classification
Pathophysiology
Causes
Differentiating Scleroderma from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Electrocardiogram
Chest X Ray
CT Scan
Echocardiography or Ultrasound
Other Imaging Findings
Treatment
Medical Therapy
Surgery
Prevention
References
- ↑ Klippel J (ed). Systemic sclerosis and related syndromes. Primer on the rheumatic diseases, 11th edition. The Arthritis Society. 1997;269. ISBN 1-91242-316-2.